Stifel Nicolaus Upgrades Amedisys (AMED) to Buy
More News related to AMED
- Amedisys (AMED) Releases Review Report from Marwood Group Advisory
- Amedisys Releases Report from Marwood Group Advisory
- Amedisys to Present at the Oppenheimer 20th Annual Healthcare Conference
- Stifel Nicolaus Upgrades Amedisys (AMED) to Buy
- Amedisys (AMED) options active after reaffirming FY2009 guidance
More News related to Upgrades
- Waterside Capital (WSCC) Reports a Quarterly Loss
- Ship Finance (SFL) Posts Q3 adj.-EPS of $0.47, Misses Estimates
- Frontline (FRO) Posts Q3 Loss of $0.07, Beats Street by 5c
Stifel Nicolaus upgrades Amedisys (Nasdaq: AMED) from Hold to Buy.
To see more analyst ratings on AMED Click Here.
Amedisys, Inc. provides home health and hospice services to the chronic, co-morbid, and aging American population.
Related Categories
UpgradesStocks Mentioned
-1.11Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
